Clinical Trials

NCT01841723 | ACTIVE_NOT_RECRUITING | PHASE2
44 participants

Ibrutinib in Treating Patients With Relapsed Hairy Cell Leukemia

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-13
Start Date:
2013-04-30
Completion:
2029-12-31
Conditions
  • Hairy Cell Leukemia
  • Hairy Cell Leukemia Variant
  • Recurrent Hairy Cell Leukemia
  • Recurrent Hairy Cell Leukemia Variant
Interventions
  • PROCEDURE
  • DRUG
No Results Yet
NCT01089101 | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2
217 participants

Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-13
Start Date:
2010-07-07
Completion:
2026-01-17
Conditions
  • Low Grade Glioma
  • Recurrent Childhood Pilocytic Astrocytoma
  • Recurrent Neurofibromatosis Type 1
  • Recurrent Visual Pathway Glioma
  • Refractory Neurofibromatosis Type 1
  • Refractory Visual Pathway Glioma
Interventions
  • PROCEDURE
  • DRUG
No Results Yet
NCT07582380 | NOT_YET_RECRUITING | NA
3600 participants

National Institute for Health and Care Research Global Health Research Centre for Multiple Long-Term Conditions

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-12
Start Date:
2026-05-05
Completion:
2026-07-30
Conditions
  • Chronic Conditions, Multiple
  • Diseases of the Circulatory System
  • Diseases of the Respiratory System
  • Endocrine, Nutritional and Metabolic Diseases
  • Mental, Behavioral and Neurodevelopmental Disorders
  • Diseases of the Musculoskeletal System and Connective Tissue
  • Diseases of the Ear and Mastoid Process
  • Diseases of the Eye and Adnexa
Interventions
  • OTHER
No Results Yet
NCT07582185 | NOT_YET_RECRUITING | PHASE4
122 participants

Tdose Binding and Tocilizumab

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-12
Start Date:
2026-06-01
Completion:
2026-09-30
Conditions
  • Rheumatoid Arthritis
Interventions
  • DRUG
No Results Yet
NCT07582172 | NOT_YET_RECRUITING | PHASE2
35 participants

Total Marrow and Lymphoid Irradiation in Combination With Fludarabine and Melphalan as Conditioning for Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplant in Older Patients With Refractory and Relapsed Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-12
Start Date:
2027-04-05
Completion:
2029-04-05
Conditions
  • Acute Myeloid Leukemia With Complex Karyotype
  • Myelodysplastic Chronic Myelomonocytic Leukemia
  • Myelodysplastic Syndrome
  • Recurrent Acute Myeloid Leukemia
  • Recurrent Myelodysplastic Chronic Myelomonocytic Leukemia
  • Recurrent Myelodysplastic Syndrome
  • Recurrent Secondary Acute Myeloid Leukemia
  • Refractory Acute Myeloid Leukemia
  • Refractory Myelodysplastic Chronic Myelomonocytic Leukemia
  • Refractory Myelodysplastic Syndrome
  • Refractory Secondary Acute Myeloid Leukemia
Interventions
  • PROCEDURE
  • DRUG
  • BIOLOGICAL
  • OTHER
  • RADIATION
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page